APAC Healthcare Weekly (September 21)– Fosun Pharm, Chugai, Astellas, SK Biopharm, Alteogen, HK Inno
Fosun Pharma and Astellas got new drug approvals. Chugai and SK Biopharma announced positive Phase 3 trial result. Alteogen’s technology powered...
709 Views
Pharmaceuticals: IPM: steady 8% growth in Aug-25
As per IQVIA, IPM saw 8.1% YoY growth in Aug-25 (7.1%% YoY in Jul-25, 9% YoY in Q1FY26, and 8% in FY25) with 0.8% YoY decline in units.
195 Views
APAC Healthcare Weekly (September 7) – Eisai, Hansoh, Hengrui, Celltrion, SK Bioscience, Lupin
Eisai initiated FDA submission of Leqembi subcutaneous injection as starting dose. Hansoh and Hengrui got approvals for new drugs. Celltrion got...
583 Views
Axis Top Picks for the month of September 2025
Axis Top Picks Basket delivered a return of 16.2% in the last six months against the 10.4% returns posted by Nifty 50, outperforming the Nifty 50...
223 Views
Axis Intellect - Balanced
Stock investment endeavors to deliver consistent outperformance over the long term by making a diversified investment of ‘Winners
221 Views